Clinical trials in Sri Lanka
130 studies list at least one site in Sri Lanka. 22 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Sri Lanka recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
CENTOGENE GmbH Rostock (28) · University of Colombo (6) · The George Institute (5) · University of Edinburgh (4) · Ministry of Health, Sri Lanka (4) · Otsuka Pharmaceutical Development & Commercialization, Inc. (3) · Colorado Prevention Center (3) · University of Kelaniya (3)
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered2
- Community Health Promotion for COVID-19 Prevention and NCD Risk Reduction in Rural Sri LankaNov 10, 2026NCT07929363
- Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasEOct 14, 2026NCT07874139
Studies
Recruiting first, then most recently updated. Showing 50 of 130 — search for more.
- HFrEF Polypill in Sri Lanka RCTRecruitingNCT07569640Phase 3
- Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasERecruitingNCT07874139
- Skin Type Determination Using Image Artificial IntelligenceRecruitingNCT07765303
- The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic EffectRecruitingNCT06058585Phase 3
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)RecruitingNCT06024746Phase 3
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsRecruitingNCT06008197Phase 3
- Administering Atropine Through Autoinjectors Within Ambulance Services for Poisoning Patients in Sri Lanka's North Central ProvinceNot yet recruitingNCT07581301
- Study of WAL0921 in Patients With Glomerular Kidney DiseasesRecruitingNCT06466135Phase 2
- TREATment of Lower Respiratory Tract Infection in Selected Hospitals in Southern Sri Lanka (TREAT-SL): a Stepped-Wedge Cluster Randomized TrialRecruitingNCT06331364Not applicable
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsRecruitingNCT06033950Phase 3
- Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)Enrolling by invitationNCT05248659Phase 2/3
- Physical Inactivity Among Patients With Cardiovascular RiskNot yet recruitingNCT07440056Not applicable
- ICU-related Out of Pocket Expenses (ICOPE)RecruitingNCT07439692
- Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE StudyRecruitingNCT05164263Phase 4
- Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)RecruitingNCT07066267Not applicable
- Comparing Efficacy of Dry Needling Combined with Passive Stretching and Muscle Energy Technique on Myofascial Trigger PointsRecruitingNCT06780904Not applicable
- SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 DiabetesRecruitingNCT05345327Phase 3
- Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific RegionRecruitingNCT03138941
- Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral CancerNot yet recruitingNCT06711848Not applicable
- A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cognitive Therapy for Patients Having Residual Depressive SymptomsRecruitingNCT06456931Not applicable
- Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)RecruitingNCT05395195Phase 3
- The Feasibility And Efficacy Of A Telerehabilitation Program For People With Knee Osteoarthiritis In Sri LankaEnrolling by invitationNCT06268925Not applicable
- Community Health Promotion for COVID-19 Prevention and NCD Risk Reduction in Rural Sri LankaCompletedNCT07929363Not applicable
- A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrolCompletedNCT07784647
- Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)Active, not recruitingNCT05248646Phase 3
- Safety and Efficacy Study of VIS649 for IgA NephropathyCompletedNCT04287985Phase 2
- Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and EntyvioTerminatedNCT06570772Phase 3
- Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenCompletedNCT02747927Phase 3
- Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene TherapyCompletedNCT05044845
- Motivational Interviewing in the Management of Non Alcoholic Fatty Liver DiseaseCompletedNCT06348628Not applicable
- Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 InfectionTerminatedNCT05109611Phase 3
- Spatial Repellents for Aedes-borne Virus Control in Sri LankaCompletedNCT05452447Not applicable
- Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialCompletedNCT02699645Phase 3
- Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionCompletedNCT04518293Phase 3
- Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionCompletedNCT04518306Phase 3
- Preventing Adverse Cardiac Events in COPDCompletedNCT03917914Phase 3
- Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri LankaCompletedNCT06831864Phase 1
- Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576CompletedNCT03588026Phase 3
- Clinical Trial on 7-day Followed by Maintenance Therapy for 10 Weeks Vs. 14-day and No Maintenance Course of Prednisolone for the Treatment of Infantile Epileptic Spasms Syndrome (IESS)Active, not recruitingNCT06838559Phase 4
- Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility StudyCompletedNCT02341651Not applicable
- Early Palliative Care for Patients with Oral Cancer in Sri LankaCompletedNCT06726317Not applicable
- Filgotinib in Long-Term Extension Study of Adults With Crohn's DiseaseTerminatedNCT02914600Phase 3
- Comparison of Thoracic Mobility Exercise Versus Manual Release Technique in Minimizing Upper Back PainCompletedNCT06340542Not applicable
- Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)TerminatedNCT05125068Phase 2
- Aspirin for Dukes C and High Risk Dukes B Colorectal CancersActive, not recruitingNCT00565708Phase 3
- Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseCompletedNCT02914561Phase 3
- Effectiveness of a Motivated, Action-based Intervention on Health Outcomes of Coronary Heart Disease PatientsSuspendedNCT05051774Not applicable
- Biomarker for Metachromatic Leukodystrophy (BioMeta) DiseaseWithdrawnNCT01536327
- Biomarker for Glycogen Storage Diseases (BioGlycogen)WithdrawnNCT02385162
- Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)WithdrawnNCT02298673